Hear this! Potential therapeutics for COVID-19 should be tested for auditory safety.

As the COVID-19 pandemic continues to spread across the world, clinicians, academic institutions, private organizations, and governments are working tirelessly to find treatments to help patients and at-risk populations threatened by this novel disease.

Fujifilm Concludes a Manufacturing Contract Agreement with VLP Therapeutics, for a COVID-19 Vaccine Formulation.

FUJIFILM Corporation announces the conclusion of a manufacturing contract agreement with VLP Therapeutics Japan LLC regarding COVID-19...

Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial.

Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the U.S. FDA to expand the enrollment of their Phase 3 pivotal COVID-19 vaccine trial...

FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients.

FSD Pharma Inc. announced that the U.S. FDA has authorized the initiation of a Phase 2 study for the use of FSD201 to treat COVID-19, the disease caused...

Regenerons REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients.

Regeneron Pharmaceuticals, Inc. announced the first data from a descriptive analysis of a seamless Phase 1/2/3 trial of its investigational antibody cocktail...

PCI Pharma Services Introduces First-of-its-Kind Digital Platform to Provide Clients with Real-Time Supply.

PCI Pharma announced the launch of pci bridge, an innovative digital platform that will give customers immediate visibility into their clinical and commercial supply chain, and provide instantaneous data...

Aptar Pharma to Unveil its State-of-the-Art Virtual Booth at CPhI Festival of Pharma.

Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, is pleased to announce its Platinum Sponsorship of the CPhI Festival of Pharma...

CPhI Pharma Index: Italy and India the only pharma economies to improve score in 2020.

Ahead of the CPhI Festival of Pharma the CPhI Pharma Index shows only Italy and India have improved their score in 2020, with the majority of industry executives looking for new supply chain partners....

High Purity New England Supports Drug Development Pipelines with Fully Customizable and Flexible Single-Use Assembly Solution.

Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025.